首页> 外文期刊>Basic & clinical pharmacology & toxicology. >PJ34, a poly adenosine diphosphate-ribose polymerase inhibitor, attenuates chromate-induced nephrotoxicity.
【24h】

PJ34, a poly adenosine diphosphate-ribose polymerase inhibitor, attenuates chromate-induced nephrotoxicity.

机译:PJ34是一种多聚腺苷二磷酸核糖聚合酶抑制剂,可减轻铬酸盐诱导的肾毒性。

获取原文
获取原文并翻译 | 示例
           

摘要

Potassium dichromate (K(2)Cr(2)O(7))-induced nephrotoxicity is associated with oxidative stress. In addition, the activation of the polyadenosine diphosphate-ribose [poly(ADP-ribose)] polymerase-1 (PARP-1) plays a role in the pathophysiology of some diseases associated with oxidative stress. To clarify the potential role of PARP-1 in this experimental model, N-(6-oxo-5,6-dihydro-phenanthridin-2-yl)-N,N-dimethyacetamide HCl (PJ34), a highly specific inhibitor of this enzyme, was used. Nephrotoxicity was induced in rats by a single sc injection of K(2)Cr(2)O(7); studies were performed 2 days later. PJ34 was given intraperitoneally (15 mg/kg) 1 hr before and 1, 5, 24, 26, 31 and 46 hr after K(2)Cr(2)O(7) injection. Nephrotoxicity was evaluated by histological analysis and by measuring blood urea nitrogen, serum creatinine, serum glutathione peroxidase activity and urinary excretion of N-acetyl-beta-D-glucosaminidase. PARP-1 activation was evaluated by the immunostaining of poly(ADP-ribose). In addition, the following markers of oxidative stress were evaluated: 3-nitrotyrosine, 4-hydroxy-2-nonenal, malondialdehyde and protein carbonyl content. K(2)Cr(2)O(7) increased poly(ADP-ribose) content suggesting the PARP-1 activation in this model. PJ34 significantly ameliorated the K(2)Cr(2)O(7)-induced: (i) nephrotoxicity, (ii) poly(ADP-ribose) accumulation and (iii) oxidative stress. It is concluded that PARP-1 is activated and involved, at least in part, in K(2)Cr(2)O(7)-induced nephrotoxicity in rats.
机译:重铬酸钾(K(2)Cr(2)O(7))诱导的肾毒性与氧化应激相关。此外,多腺苷二磷酸核糖[聚(ADP-核糖)]聚合酶-1(PARP-1)的激活在某些与氧化应激有关的疾病的病理生理中也起作用。为了阐明PARP-1在此实验模型中的潜在作用,N-(6-氧代-5,6-二氢菲啶-2-基)-N,N-二甲基乙酰胺盐酸盐(PJ34)是该抑制剂的高度特异性抑制剂使用酶。肾毒性通过单次皮下注射K(2)Cr(2)O(7)诱导大鼠。 2天后进行研究。在注射K(2)Cr(2)O(7)之前1小时,1、5、24、26、31和46小时腹膜内给予PJ34(15 mg / kg)。通过组织学分析和通过测量血液尿素氮,血清肌酐,血清谷胱甘肽过氧化物酶活性和N-乙酰基-β-D-葡萄糖苷酶的尿排泄来评估肾毒性。通过聚(ADP-核糖)的免疫染色评估PARP-1的活化。此外,还评估了以下氧化应激指标:3-硝基酪氨酸,4-羟基-2-壬烯醛,丙二醛和蛋白质羰基含量。 K(2)Cr(2)O(7)增加了聚(ADP-核糖)的含量,表明该模型中的PARP-1激活。 PJ34大大改善了K(2)Cr(2)O(7)诱导的:(i)肾毒性,(ii)聚(ADP-核糖)积累和(iii)氧化应激。结论是,PARP-1被激活并至少部分参与了大鼠的K(2)Cr(2)O(7)诱导的肾毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号